| | | | | | | | | | |
|
|
| Dockets Entered
On December 23, 2004
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 2002N-0277
|
| Bioterrorism; Establishment & Maintenance of Records
|
|
|
| 2003F-0088
|
| Increase the Maximum Permitted Energy Level of X-rays
|
|
|
| 2003M-0172
|
| PMA Cypher Sirolimus-Eluting Coronary Stent on the Raptor
|
|
|
| 2003P-0531
|
| Issue a report providing the necessary information on pill weight tolerances and/or variations caused by reformulations
|
|
|
| 2004D-0327
|
| Guidance for Small Business Entities on Labeling Over-the-Counter Human Drug Products; Availability
|
|
|
| 2004D-0369
|
| Recommendations for the Early Food Safety Evaluation of New Non-Pesticidal Proteins Produced by Bioengineered Plants Intended for Food Use
|
|
|
| 2004D-0440
|
| Guidance for Industry on Computerized Systems Used in Clinical Trials
|
|
|
| 2004D-0443
|
| Guidance for Industry on Quality Systems Approach to Pharmaceutical Current Good Manufacturing Regulations
|
|
|
| 2004D-0453
|
| Compliance Policy Guide Sec. 560.400 - "Imported Milk and Cream Federal Import Milk Act (CPG 7119.05)"
|
|
|
| 2004G-0381
|
| Records Access Authority Provided in Title III, Subtitle A, of the Public Health Security and Bioterrorism Preparedness and Response Act of 2002
|
|
|
| 2004M-0309
|
| P020023 - Restylane Injectable Gel
|
|
|
| 2004M-0310
|
| P020030 - Stelid II steroid eluting pacing leads, Approved 6/17/04
|
|
|
| 2004M-0312
|
| P970043/S015- LADARVision 4000 Excimer Laser System, Approved 6/29/04
|
|
|
| 2004M-0313
|
| P030054 - St. Jude Medical Epic HF System, Approved 6/30/04
|
|
|
| 2004M-0323
|
| Premarket Approval for ImageChecker CT CAD Software System - Model LN-1000 by R2 Technology, Inc., Approved 7/8/04 (P030012)
|
|
|
| 2004M-0341
|
| P030024 - Vitros Immunodiagnostic Products Anti-HBc Reagent Pack and Vitros Immunodiagnostic Products Anti-HBc Calibrator
|
|
|
| 2004M-0342
|
| P040008 - VIDAS TPSA assay
|
|
|
| 2004M-0345
|
| Premarket Approval for CureLight BroadBand by PhotoCure ASA (Model CureLight 01) P010061
|
|
|
| 2004M-0350
|
| Premarket Approval for Sculptra - P030050
|
|
|
| 2004M-0356
|
| P030026 - Vitros Immunodiagnostic Products Anti-HBc IgM Reagent Pack and Vitros Immunodiagnostic Products Anti-HBc IgM Calibrator
|
|
|
| 2004M-0387
|
| P030010 - Siemens Mammomat Novation Full Field Digital Mammography System,
|
|
|
| 2004M-0388
|
| P040012 - ACCULINK Carotid Stent System and RX ACCULIN Carotid Stent System
|
|
|
| 2004M-0403
|
| P030025 - TAXUS Express2 Paclitaxel-Eluting Coronary Stent System (Monorail and Over-the-Wire)
|
|
|
| 2004M-0415
|
| H030009 - Vertical Expandable Prosthetic Titanium Rib (VEPTR)
|
|
|
| 2004M-0430
|
| P010012/S026 - CONTAK CD (Model 1823), CONTAK CD 2 (Models H115 and H119), RENEWAL (Model H135), RENEWAL 3 (Models H170, H175, H177, and H179)
|
|
|
| 2004M-0433
|
| P030044 - DakoCytomation EGFR pharmDx
|
|
|
| 2004N-0432
|
| Radioactive Drugs for Certain Research Uses; Public Meeting
|
|
|
| 2004N-0479
|
| Draft Risk Assessment of Streptogramin Resistance in Enterococcus faecium Attributable to the Use of Streptogramins in Animals; Availability
|
|
|
| 2004P-0519
|
| Cottage Cheese Deviating from Identity Standard; Temporary Permit for Market Testing
|
|
|
| 2004P-0520
|
| 180-Day Exclusivity for Ipratropium Bromide and Albuterol Sulfate Inhalation solution
|
|
|
| 2002N-0277
|
| Bioterrorism; Establishment & Maintenance of Records
|
|
| BKG
2
References
|
| References 1 - 29
|
| Vol #:
|
| 20
|
|
|
| NFR
1
|
| FDA
|
| Vol #:
|
| 19
|
|
|
| NM
2
|
| FDA
|
| Vol #:
|
| 16
|
|
|
| 2003F-0088
|
| Increase the Maximum Permitted Energy Level of X-rays
|
|
| | | | | | | | |
|
|
| BKG
1
|
| Background Material Refs 1 - 4
|
| Vol #:
|
| 1
|
|
|
| NFR
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2003M-0172
|
| PMA Cypher Sirolimus-Eluting Coronary Stent on the Raptor
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2003P-0531
|
| Issue a report providing the necessary information on pill weight tolerances and/or variations caused by reformulations
|
|
|
| LET
2
|
| Fulcrum Inc.
|
| Vol #:
|
| 1
|
|
|
| 2004D-0327
|
| Guidance for Small Business Entities on Labeling Over-the-Counter Human Drug Products; Availability
|
|
|
| GDL
1
|
| Guideline
|
| Vol #:
|
| 1
|
|
|
| NAD
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004D-0369
|
| Recommendations for the Early Food Safety Evaluation of New Non-Pesticidal Proteins Produced by Bioengineered Plants Intended for Food Use
|
|
|
| C 8
|
| J. Bencharsky
|
| Vol #:
|
| 1
|
|
|
| C 9
|
| C. Ristad
|
| Vol #:
|
| 1
|
|
|
| C 10
|
| J. Wright
|
| Vol #:
|
| 1
|
|
|
| C 11
|
| D. Shelton
|
| Vol #:
|
| 1
|
|
|
| C 12
|
| W. Rougle
|
| Vol #:
|
| 1
|
|
|
| C 13
|
| H. Koelle
|
| Vol #:
|
| 1
|
|
|
| C 14
|
| C. Whitney
|
| Vol #:
|
| 1
|
|
|
| C 15
|
| Form Letters
|
| Vol #:
|
| 3
|
|
|
| C 16
|
| Form Letters
|
| Vol #:
|
| 4
|
|
|
| C 17
|
| Form Letters
|
| Vol #:
|
| 5
|
|
|
| C 18
|
| Form Letters
|
| Vol #:
|
| 6
|
|
|
| 2004D-0440
|
| Guidance for Industry on Computerized Systems Used in Clinical Trials
|
|
| C
3
|
| Animal Health Institute (AHI)
|
| Vol #:
|
| 1
|
|
|
| C
4
|
| ISPE
|
| Vol #:
|
| 1
|
|
|
| C
5
|
| GlaxoSmithKline (GSK)
|
| Vol #:
|
| 1
|
|
|
| C
6
|
| Genentech
|
| Vol #:
|
| 1
|
|
|
| C
7
|
| Aventis Pasteur Inc.
|
| Vol #:
|
| 1
|
|
|
| C
8
|
| Bristol-Myers Squibb Company (BMS)
|
| Vol #:
|
| 1
|
|
|
| 2004D-0443
|
| Guidance for Industry on Quality Systems Approach to Pharmaceutical Current Good Manufacturing Regulations
|
|
|
| C
16
|
| Active Pharmaceutical Ingredients Committee (APIC)
|
| Vol #:
|
| 2
|
|
|
| 2004D-0453
|
| Compliance Policy Guide Sec. 560.400 - "Imported Milk and Cream Federal Import Milk Act (CPG 7119.05)"
|
|
|
| C
6
|
| National Farmers Oraganization (NFO)
|
| Vol #:
|
| 1
|
|
| | | | | | | | |
|
|
| 2004G-0381
|
| Records Access Authority Provided in Title III, Subtitle A, of the Public Health Security and Bioterrorism Preparedness and Response Act of 2002
|
|
|
| GDL
1
|
| Guideline
|
| Vol #:
|
| 1
|
|
|
| NAD
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004M-0309
|
| P020023 - Restylane Injectable Gel
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004M-0310
|
| P020030 - Stelid II steroid eluting pacing leads, Approved 6/17/04
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004M-0312
|
| P970043/S015- LADARVision 4000 Excimer Laser System, Approved 6/29/04
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004M-0313
|
| P030054 - St. Jude Medical Epic HF System, Approved 6/30/04
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004M-0323
|
| Premarket Approval for ImageChecker CT CAD Software System - Model LN-1000 by R2 Technology, Inc., Approved 7/8/04 (P030012)
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004M-0341
|
| P030024 - Vitros Immunodiagnostic Products Anti-HBc Reagent Pack and Vitros Immunodiagnostic Products Anti-HBc Calibrator
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004M-0342
|
| P040008 - VIDAS TPSA assay
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004M-0345
|
| Premarket Approval for CureLight BroadBand by PhotoCure ASA (Model CureLight 01) P010061
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004M-0350
|
| Premarket Approval for Sculptra - P030050
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004M-0356
|
| P030026 - Vitros Immunodiagnostic Products Anti-HBc IgM Reagent Pack and Vitros Immunodiagnostic Products Anti-HBc IgM Calibrator
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004M-0387
|
| P030010 - Siemens Mammomat Novation Full Field Digital Mammography System,
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004M-0388
|
| P040012 - ACCULINK Carotid Stent System and RX ACCULIN Carotid Stent System
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004M-0403
|
| P030025 - TAXUS Express2 Paclitaxel-Eluting Coronary Stent System (Monorail and Over-the-Wire)
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
| | | | | | | | |
|
|
| 2004M-0415
|
| H030009 - Vertical Expandable Prosthetic Titanium Rib (VEPTR)
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004M-0430
|
| P010012/S026 - CONTAK CD (Model 1823), CONTAK CD 2 (Models H115 and H119), RENEWAL (Model H135), RENEWAL 3 (Models H170, H175, H177, and H179)
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004M-0433
|
| P030044 - DakoCytomation EGFR pharmDx
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004N-0432
|
| Radioactive Drugs for Certain Research Uses; Public Meeting
|
|
|
| C
2
|
| Kettering Medical Center
|
| Vol #:
|
| 2
|
|
|
| EXT
3
|
| Washington University in St. Louis
|
| Vol #:
|
| 2
|
|
|
| EXT
4
|
| University of Southern California (USC)
|
| Vol #:
|
| 2
|
|
|
| 2004N-0479
|
| Draft Risk Assessment of Streptogramin Resistance in Enterococcus faecium Attributable to the Use of Streptogramins in Animals; Availability
|
|
|
| EXT
1
|
| Phibro Animal Health
|
| Vol #:
|
| 1
|
|
|
| 2004P-0519
|
| Cottage Cheese Deviating from Identity Standard; Temporary Permit for Market Testing
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004P-0520
|
| 180-Day Exclusivity for Ipratropium Bromide and Albuterol Sulfate Inhalation solution
|
|
|
| C
1
Enclosure
A, B
|
| Eon Labs
|
| Vol #:
|
| 1
|
|